Albinism: Clinical Trials

2 trials for Albinism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Not yet recruiting 1, Recruiting 1

Follow Albinism: new trials by email Literature Review of Albinism trials Research Report on Albinism

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department
Haloperidol - Cannabinoid Hyperemesis Syndrome
Early Phase 1Not yet recruitingUniversity of Illinois at Chicago1002026-11-012026-09-01
Safety and Efficacy of a Single Suprachoroidal Injection of JWK010 Gene Therapy in Subjects With Oculocutaneous Albinism Type 1 (OCA1)
JWK010 gene therapy - Oculocutaneous Albinism (OCA)
Early Phase 1RecruitingWest China Hospital182025-12-222026-01-12

Narrower conditions

Albinism, Oculocutaneous (1)  ·  Cannabinoid Hyperemesis Syndrome (1)  ·  Chediak-Higashi Syndrome (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Eye Diseases (2)  ·  Eye Diseases, Hereditary (2)  ·  Genetic Diseases, Inborn (2)  ·  Amino Acid Metabolism, Inborn Errors (1)  ·  Chemically-Induced Disorders (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hypopigmentation (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Leukocyte Disorders (1)  ·  Marijuana Abuse (1)  ·  Mental Disorders (1)

Interventions

Haloperidol (1)

Sponsors

University of Illinois at Chicago (1)  ·  West China Hospital (1)

Countries

China (1)  ·  United States (1)

Top investigators

Fang Lu (1)  ·  Wesley Eilbert, MD (1)